In Re Metoprolol Succinate Patent Lit.
United States Judicial Panel on Multidistrict Litigation
1Opinion of the Court
329 F.Supp.2d 1368 (2004)
In re METOPROLOL SUCCINATE PATENT LITIGATION
Astrazeneca AB, et al.
v.
Andrx Pharmaceuticals, LLC, et al., D. Delaware, C.A. No. 1:04-80
Astrazeneca AB, et al.,
v.
Eon Labs, Inc., D. Delaware, C.A. No. 1:04-205
Astrazeneca AB, et al.,
v.
KV Pharmaceutical Co., E.D. Missouri, C.A. No. 4:03-592
Astrazeneca AB, et al.,
v.
KV Pharmaceutical Co., E.D. Missouri, C.A. No. 4:03-1169
No. 1620, 1:04-80, 1:04-205, 4:03-592, 4:03-1169.
Judicial Panel on Multidistrict Litigation.
August 9, 2004.
Before WM. TERRELL HODGES, Chairman, JOHN F. KEENAN, D. LOWELL JENSEN, J. FREDERICK MOTZ, ROBERT L.…
2Cases cited1 opinion
- AstraZeneca AB v. Andrx Pharmaceuticals, LLCUnited States Judicial Panel on Multidistrict Litigation · 2004
3Cited by5 opinions
- In Re Brimonidine Patent LitigationUnited States Judicial Panel on Multidistrict Litigation · 2007
- In Re ALFUZOSIN HYDROCHLORIDE PATENT LITIGATIONUnited States Judicial Panel on Multidistrict Litigation · 2008
- Forest Laboratories Inc. v. Torrent Pharmaceuticals Ltd.United States Judicial Panel on Multidistrict Litigation · 2012
- In Re Desloratadine Patent LitigationUnited States Judicial Panel on Multidistrict Litigation · 2007
- In re Kerydin (Tavaborole) Topical Solution 5% Patent Litig.United States Judicial Panel on Multidistrict Litigation · 2019